| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |